Alfonso Illiano
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: The Italian NSCLC expanded access program.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 12, 2019
Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 14, 2018
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations.
Journal: British journal of cancer
Published: May 12, 2018
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients.
Journal: Cancer cytopathology
Published: January 11, 2013
EGFR mutations detection on liquid-based cytology: is microscopy still necessary?
Journal: Journal of clinical pathology
Published: April 03, 2012
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.
Journal: The Lancet. Oncology
Published: January 31, 2012
Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 03, 2011
EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study.
Journal: Journal of clinical pathology
Published: September 28, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026